A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, Benito Sánchez-Llamas et al.|Clinical Cancer Research|2011Cited by 32
Data from A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, José Javier Sánchez et al.|Unknown|2023Cited by 0
Data from A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, José Javier Sánchez et al.|Unknown|2023Cited by 0
Supplementary Data from A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, José Javier Sánchez et al.|Unknown|2023Cited by 0
Supplementary Data from A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, José Javier Sánchez et al.|Unknown|2023Cited by 0